How many insider declarations has Kaplan Andrew T. filed?

Kaplan Andrew T. has filed 3 public insider declarations with SEC (Form 4).

What is Kaplan Andrew T.'s role?

Kaplan Andrew T.'s reported role is not specified by the regulator across the filings.

Which companies does Kaplan Andrew T. report trades for?

Kaplan Andrew T. reports trades for 2 companies, including Surgery Partners, Inc..

What is Kaplan Andrew T.'s declared buy vs sell volume?

Across the available history, declared buys total 114.0M€ and disposals 239.6M€.

← Executives ★ Sign in to follow

KA

Kaplan Andrew T.

·SEC (Form 4)

Surgery Partners, Inc.Kailera Therapeutics, Inc.

0

申报总数

0

公司

€1亿

▲ 买入（1 笔）

€2亿

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

1

T+90 胜率

0%

T+90 平均收益

-29.0%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Explore the full record of transactions filed by Kaplan Andrew T.. Officer active across 2 companies, notably Surgery Partners, Inc.. In total, 3 reports have been recorded. Split: 1 buy · 1 sell. Total volume traded: €353.6m. History available since 19 December 2023. The latest transaction was disclosed on 20 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Kaplan Andrew T.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Surgery Partners, Inc. (US)Kailera Therapeutics, Inc. (US)

申报3 总计

▲

Kaplan Andrew T.

Director高管2026年4月20日Kailera Therapeutics, Inc.

US$1亿41SEC ↗

8,398,438 股@ US$16.00100.0% 占其流量Common StockSEC:0001193125-26-164388:1

标准退出：2026年7月19日 (T+90)

●

Kaplan Andrew T.

Director高管2026年4月20日Kailera Therapeutics, Inc.

0SEC ↗

17,857,143 股Common StockSEC:0001193125-26-164388:0

▼

Kaplan Andrew T.

Director高管2023年12月19日Surgery Partners, Inc.

US$3亿37SEC ↗

7,826,870 股@ US$33.44100.0% 占其流量Common StockSEC:0000950170-23-072382:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

KA

Kaplan Andrew T.

·SEC (Form 4)

Surgery Partners, Inc.Kailera Therapeutics, Inc.

0

申报总数

0

公司

€1亿

▲ 买入（1 笔）

€2亿

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

1

T+90 胜率

0%

T+90 平均收益

-29.0%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Explore the full record of transactions filed by Kaplan Andrew T.. Officer active across 2 companies, notably Surgery Partners, Inc.. In total, 3 reports have been recorded. Split: 1 buy · 1 sell. Total volume traded: €353.6m. History available since 19 December 2023. The latest transaction was disclosed on 20 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.